← Leaderboards
Wael Saber
Fred Hutchinson Cancer Research Center
$862,232
Attributed
$1,724,463
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $438.5K · FY2015–18$500K$375K$250K$125K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$1,724,463 · 1
By mechanism
R01$1,724,463 · 1
Top collaborators
- Scott D Ramsey4 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Effie W Petersdorf$50,293,518
- Rainer F. Storb$23,835,935
- Brenda Marie Sandmaier$22,185,663
- Paul J Martin$18,480,958
- Jonathan B Bricker$29,660,669
Others in their field
Top investigators on “Cost Effectiveness Analysis”
- Jeffrey P Krischer · University Of South Florida$242,073,622
- Richard K. Wilson · Washington University$213,425,499
- George R Seage · Abt Associates, Inc.$117,956,401
- Richard A Gibbs · Baylor College Of Medicine$85,846,608
- Jeffrey H Samet · Boston University Medical Campus$81,990,993
- David Heimbrook · Leidos Biomedical Research, Inc.$81,937,613
Research focus
Cost Effectiveness AnalysisAlternative TreatmentBeneficiaryAgedBloodBone Marrow DiseasesBone Marrow TransplantationBudgetsCaregiversAllogenicClinical Practice GuidelineClinical ResearchClinical TrialsClinical Trials NetworkComorbidityComparativeComplementConditioningConfidence IntervalsCostCellsCost EffectiveCost EffectivenessData Analyses
Grant awards (4)
Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients$432,375
R01 · FY2018 · HL
Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients$432,539
R01 · FY2017 · HL
Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients$438,455
R01 · FY2016 · HL
Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients$421,094
R01 · FY2015 · HL